These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7740452)

  • 1. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
    Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation.
    Wachtfogel YT; Kettner C; Hack CE; Nuijens JH; Reilly TM; Knabb RM; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1998 Oct; 80(4):686-91. PubMed ID: 9798991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation.
    Sundaram S; Gikakis N; Hack CE; Niewiarowski S; Edmunds LH; Koneti Rao A; Sun L; Cooper SL; Colman RW
    Thromb Haemost; 1996 Jan; 75(1):76-82. PubMed ID: 8713783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.
    Wachtfogel YT; Hack CE; Nuijens JH; Kettner C; Reilly TM; Knabb RM; Bischoff R; Tschesche H; Wenzel H; Kucich U
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H1352-7. PubMed ID: 7535008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation.
    Gikakis N; Khan MM; Hiramatsu Y; Gorman JH; Hack CE; Sun L; Rao AK; Niewiarowski S; Colman RW; Edmunds LH
    Circulation; 1996 Nov; 94(9 Suppl):II341-6. PubMed ID: 8901772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation.
    Rinder CS; Smith MJ; Rinder HM; Cortright DN; Brodbeck RM; Krause JE; Smith BR
    Ann Thorac Surg; 2007 Jan; 83(1):146-52. PubMed ID: 17184649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
    Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.
    Schapira M; Ramus MA; Waeber B; Brunner HR; Jallat S; Carvallo D; Roitsch C; Courtney M
    J Clin Invest; 1987 Aug; 80(2):582-5. PubMed ID: 3497179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood activation during neonatal extracorporeal life support.
    Plötz FB; van Oeveren W; Bartlett RH; Wildevuur CR
    J Thorac Cardiovasc Surg; 1993 May; 105(5):823-32. PubMed ID: 7683735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
    Schapira M; Ramus MA; Jallat S; Carvallo D; Courtney M
    J Clin Invest; 1986 Feb; 77(2):635-7. PubMed ID: 3484756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation.
    Hiramatsu Y; Homma S; Sato Y; Sato S; Matsuzaki K; Shigeta O; Sakakibara Y
    Ann Thorac Surg; 2005 Apr; 79(4):1326-32. PubMed ID: 15797071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
    Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
    J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
    Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
    J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neutrophil degranulation during extracorporeal circulation.
    Wachtfogel YT; Kucich U; Greenplate J; Gluszko P; Abrams W; Weinbaum G; Wenger RK; Rucinski B; Niewiarowski S; Edmunds LH
    Blood; 1987 Jan; 69(1):324-30. PubMed ID: 2947645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity.
    Stahl RF; Fisher CA; Kucich U; Weinbaum G; Warsaw DS; Stenach N; O'Connor C; Addonizio VP
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):230-9. PubMed ID: 1846928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans.
    Faymonville ME; Pincemail J; Duchateau J; Paulus JM; Adam A; Deby-Dupont G; Deby C; Albert A; Larbuisson R; Limet R
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):309-17. PubMed ID: 1650868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iloprost reduces procoagulant activity in the extracorporeal circuit.
    Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
    J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.